Dr. Scott F Davies MD

Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...

When getting a life-changing diagnosis, it may be hard to discuss it with others. It is isolating when you feel others do not understand; your family and friends may not have cystic fibrosis or know people affected by the disease. You may also be dealing with shock from the new diagnosis. Chances...

Breathe in and breathe out. Isn't it one of the simplest things to do in life? But when you see your loved ones, especially your children, wheezing, it can really make you anxious and stressed. One of the most traumatizing diseases that can leave one struggling for something as basic as oxygen is...

What is rapid shallow breathing?Rapid, shallow breathing, also medically called as tachypnea, is a term used to describe a breathing that is too fast, particularly when people have it due to a lung disease or other health conditions. Sometimes, rapid, shallow breathing and hyperventilation...

Legionella bacteriaLegionnaires' disease is a type of pneumonia that is in its most severe form. The disease occurs due to a bacterial infection caused by a bacteria called legionella and mainly results in the inflammation of the lungs. The bacteria are known to thrive commonly in areas such as...

For many people with CF, remembering their daily treatment regimens and medication schedules can seem daunting and difficult. Most patients acclaim that if they had a resource, such as an app, that would make their health management easier to handle, that they would love to try it. In addition to...